Skip to main content
. 2023 Feb 12;23:63. doi: 10.1186/s12905-022-02140-y

Table 4.

Odds ratio and 95% confidence intervals of diabetic nephropathy according to following DASH diet among subjects

DASH diet
Variables Low High OR (95% CI) P value
N (case/control) (72/37) (33/68)
DASH score
Crude model 1.00 (Ref) 0.26 (0.14–0.47)  < 0.001
Model 1 1.00 (Ref) 0.20 (0.10–0.38)  < 0.001
Model 2 1.00 (Ref) 0.16 (0.07–0.34)  < 0.001
Vegetables (g/d)
Crude model 1.00 (Ref) 0.27 (0.15–0.48)  < 0.001
Model 1 1.00 (Ref) 0.24 (0.13–0.43)  < 0.001
Model 2 1.00 (Ref) 0.20 (0.10–0.39)  < 0.001
Fruits (g/d)
Crude model 1.00 (Ref) 0.23 (0.13–0.42)  < 0.001
Model 1 1.00 (Ref) 0.17 (0.08–0.32)  < 0.001
Model 2 1.00 (Ref) 0.12 (0.05–0.26)  < 0.001
Nuts and legumes (g/d)
Crude model 1.00 (Ref) 0.17 (0.09–0.32)  < 0.001
Model 1 1.00 (Ref) 0.15 (0.08–0.30)  < 0.001
Model 2 1.00 (Ref) 0.13 (0.06–0.28)  < 0.001
Low-fat dairy
Crude model 1.00 (Ref) 0.36 (0.20–0.63)  < 0.001
Model 1 1.00 (Ref) 0.33 (0.18–0.60)  < 0.001
Model 2 1.00 (Ref) 0.27 (0.14–0.52)  < 0.001
Whole grains (g/d)
Crude model 1.00 (Ref) 0.55 (0.31–0.96) 0.03
Model 1 1.00 (Ref) 0.58 (0.32–1.14) 0.06
Model 2 1.00 (Ref) 0.51 (0.27–0.95) 0.03
Sodium (mg/d)
Crude model 1.00 (Ref) 0.61 (0.32–1.17) 0.14
Model 1 1.00 (Ref) 0.63 (0.32–1.22) 0.17
Model 2 1.00 (Ref) 0.77 (0.37–1.57) 0.47
Red meat (g/d)
Crude model 1.00 (Ref) 1.31 (0.17–0.55) 0.12
Model 1 1.00 (Ref) 1.27 (0.15–0.50)  < 0.001
Model 2 1.00 (Ref) 1.20 (0.10–0.41)  < 0.001
Sweetened beverages
Crude model 1.00 (Ref) 1.12 (0.65–1.94) 0.67
Model 1 1.00 (Ref) 1.02 (0.57–1.82) 0.92
Model 2 1.00 (Ref) 1.15 (0.62–2.15) 0.64

Logistic regression was used. Significant items with a P value ≤ 0.05 are bolded

Data are presented as odds ratio (95% confidence interval)

Lower and higher adherence of median of DASH diet are shown

Model 1: Adjusted for energy intake, age, physical activity, body mass index

Model 2: model 1 + diabetes duration, cardiovascular diseases history, and drug usage (angiotensin receptor blockers; angiotensin converting enzyme inhibitors, beta-blockers, metformin, sulphonyl urea, and insulin)